Homepage2096 • HKG
add
Simcere Pharmaceutical Group Ltd
Vorige slotkoers
$Â 6,53
Dag-range
$Â 6,52 - $Â 6,80
Jaar-range
$Â 4,94 - $Â 7,87
Beurswaarde
17,13Â mld. HKD
Gem. volume
6,10Â mln.
Koers/winst
-
Dividendrendement
2,59%
Primaire beurs
HKG
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(CNY) | jun 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 1,56Â mld. | -7,93% |
Bedrijfskosten | 939,63Â mln. | -14,71% |
Netto inkomsten | 228,30Â mln. | -79,92% |
Netto winstmarge | 14,66 | -78,19% |
Winst per aandeel | — | — |
EBITDA | 345,55Â mln. | 47,98% |
Effectief belastingtarief | 7,70% | — |
Balans
Totale activa
Totale passiva
(CNY) | jun 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 3,06Â mld. | 24,38% |
Totale activa | 11,71Â mld. | -7,70% |
Totale passiva | 4,80Â mld. | 32,12% |
Totaal aandelenvermogen | 6,91 mld. | — |
Uitstaande aandelen | 2,54 mld. | — |
Koers-boekwaardeverhouding | 2,40 | — |
Rendement op activa | 6,22% | — |
Rendement op kapitaal | 9,00% | — |
Kasstroom
Nettomutatie in liquide middelen
(CNY) | jun 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 228,30Â mln. | -79,92% |
Operationele kasstroom | 431,33Â mln. | 1.152,84% |
Kasstroom uit beleggingen | -200,98Â mln. | -129,73% |
Kasstroom uit financiering | 143,27Â mln. | 159,16% |
Nettomutatie in liquide middelen | 373,91Â mln. | -5,19% |
Vrije kasstroom | 215,87Â mln. | 112,26% |
Over
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The Company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
CEO
Opgericht
1995
Hoofdvestiging
Website
Werknemers
6.412